Major depressive disorder affects up to 50% of all individuals with multiple sclerosis (MS) at some point during their lifetime and can lead to lower quality of life, greater disease progression and higher mortality. Patients ...
Sep 27, 2023
0
29
A University of Alberta researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases.
Jan 24, 2023
0
1017
Currently available therapies to treat multiple sclerosis (MS) lack precision and can lead to serious side effects. Researchers at Karolinska Institutet in Sweden have now developed a method for identifying the immune cells ...
Apr 27, 2022
0
135
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis (MS) flare-ups in patients. These gut cells seem to be playing a protective ...
Nov 20, 2020
0
435
A team of researchers affiliated with multiple institutions in Germany has found that T-cell specificity plays a major role in immune system attacks on myelin versus β-synuclein in people with multiple sclerosis. In their ...
(Medical Xpress)—A team of researchers at the University of Wisconsin has found that applying certain types of sunscreen to mice with a multiple sclerosis-like condition dissipated the symptoms of the condition. In their ...
A type of treatment for multiple sclerosis that 'resets' the immune system may stop progression of the disease in nearly half of patients.
Feb 20, 2017
0
3809
For more than 15 years, people suffering from multiple sclerosis have relied on a drug called interferon-beta to prevent flare-ups of the disease and avoid its crippling neurological symptoms.
Nov 7, 2016
0
21
Multiple sclerosis (MS), an autoimmune disease of the brain and spinal cord, affects about 2.3 million people worldwide (400,000 in the United States). Affecting more women than men, it can be seen at any age, although it ...
Dec 1, 2014
1
2
For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health ...
Jan 20, 2014
0
0
